Complication probability models for radiation-induced heart valvular dysfunction: Do heart-lung interactions play a role?

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Cella, Laura ^a,b   Palma, Giuseppe ^a   Deasy, Joseph O ^c   Oh, Jung Hun ^c   Liuzzi, Raffaele ^a,b   D'Avino, Vittoria ^a   Conson, Manuel ^a,b   Pugliese, Novella ^b   Picardi, Marco ^b   Salvatore, Marco ^b   Pacelli, Roberto ^a,b  

^a CNR   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AREA UNDER THE CURVE; ARTICLE; CARDIOTOXICITY; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; DOSE VOLUME HISTOGRAM; FRACTIONATION; HEART VALVE DYSFUNCTION; HEART VOLUME; HODGKIN DISEASE; HUMAN; LUNG VOLUME; LYMAN KUTCHER BURMAN MODEL; MAJOR CLINICAL STUDY; MATHEMATICAL MODEL; NORMAL TISSUE COMPLICATION PROBABILITY MODEL; PREDICTIVE VALUE; PROBABILITY; RADIATION DOSE; RADIATION HAZARD; RADIATION INJURY; RADIOLOGICAL PARAMETERS; RECEIVER OPERATING CHARACTERISTIC; RELATIVE SERIALITY MODEL; SENSITIVITY AND SPECIFICITY; VALVULAR HEART DISEASE; BIOLOGICAL MODEL; COMPLICATION; CONFIDENCE INTERVAL; HEART VALVE; LUNG; PATHOPHYSIOLOGY; RADIATION RESPONSE; STATISTICAL MODEL;

CONFIDENCE INTERVALS; DOSE-RESPONSE RELATIONSHIP, RADIATION; HEART VALVES; HUMANS; LIKELIHOOD FUNCTIONS; LUNG; MODELS, CARDIOVASCULAR; PROBABILITY; RADIATION INJURIES; ROC CURVE;

EID: 84910000530     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111753     Document Type: Article

References (42)

1. Gagliardi G, Constine LS, Moiseenko V, Correa C, Pierce LJ, et al. (2010) Radiation dose-volume effects in the heart. Int J Radiat Oncol Biol Phys 76: S77-85.
2. Kong FM, Pan C, Eisbruch A, Ten Haken RK (2007) Physical models and simpler dosimetric descriptors of radiation late toxicity. Semin Radiat Oncol 17: 108-120.
3. Louwe RJ, Wendling M, van Herk MB, Mijnheer BJ (2007) Three-dimensional heart dose reconstruction to estimate normal tissue complication probability after breast irradiation using portal dosimetry. Med Phys 34: 1354-1363.
4. Trott KR, Doerr W, Facoetti A, Hopewell J, Langendijk J, et al. (2012) Biological mechanisms of normal tissue damage: importance for the design of NTCP models. Radiother Oncol 105: 79-85.
5. Gagliardi G, Lax I, Ottolenghi A, Rutqvist LE (1996) Long-term cardiac mortality after radiotherapy of breast cancer-application of the relative seriality model. Br J Radiol 69: 839-846.
6. Gagliardi G, Lax I, Rutqvist LE (2001) Partial irradiation of the heart. Semin Radiat Oncol 11: 224-233.
7. Eriksson F, Gagliardi G, Liedberg A, Lax I, Lee C, et al. (2000) Long-term cardiac mortality following radiation therapy for Hodgkin's disease: analysis with the relative seriality model. Radiother Oncol 55: 153-162.
8. Maraldo MV, Brodin NP, Aznar MC, Vogelius IR, Munck Af Rosenschold P, et al. (2013) Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma. Ann Oncol 24: 2113-2118.
9. Maraldo MV, Brodin NP, Vogelius IR, Aznar MC, Munck Af Rosenschold P, et al. (2012) Risk of developing cardiovascular disease after involved node radiotherapy versus mantle field for Hodgkin lymphoma. Int J Radiat Oncol Biol Phys 83: 1232-1237.
10. Cella L, Conson M, Pressello MC, Molinelli S, Schneider U, et al. (2013) Hodgkin's lymphoma emerging radiation treatment techniques: trade-offs between late radio-induced toxicities and secondary malignant neoplasms. Radiat Oncol 8: 22.
11. Heidenreich PA, Hancock SL, Lee BK, Mariscal CS, Schnittger I (2003) Asymptomatic cardiac disease following mediastinal irradiation. J Am Coll Cardiol 42: 743-749.
12. Lancellotti P, Nkomo VT, Badano LP, Bergler-Klein J, Bogaert J, et al. (2013) Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Eur Heart J Cardiovasc Imaging 14: 721-740.
13. Kallman P, Agren A, Brahme A (1992) Tumour and normal tissue responses to fractionated non-uniform dose delivery. Int J Radiat Biol 62: 249-262.
14. Kutcher GJ, Burman C (1989) Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method. Int J Radiat Oncol Biol Phys 16: 1623-1630.
15. El Naqa I, Bradley J, Blanco AI, Lindsay PE, Vicic M, et al. (2006) Multivariable modeling of radiotherapy outcomes, including dose-volume and clinical factors. Int J Radiat Oncol Biol Phys 64: 1275-1286.
16. Cella L, Liuzzi R, Conson M, D'Avino V, Salvatore M, et al. (2013) Multivariate normal tissue complication probability modeling of heart valve dysfunction in Hodgkin lymphoma survivors. Int J Radiat Oncol Biol Phys 87: 304-310.
17. Schultz-Hector S, Sund M, Thames HD (1992) Fractionation response and repair kinetics of radiation-induced heart failure in the rat. Radiother Oncol 23: 33-40.
18. Schultz-Hector S, Trott KR (2007) Radiation-induced cardiovascular diseases: is the epidemiologic evidence compatible with the radiobiologic data? Int J Radiat Oncol Biol Phys 67: 10-18.
19. van Luijk P, Faber H, Meertens H, Schippers JM, Langendijk JA, et al. (2007) The impact of heart irradiation on dose-volume effects in the rat lung. Int J Radiat Oncol Biol Phys 69: 552-559.
20. Di Biase A, Conson M, Cella L, Pugliese N, Picardi M, et al. (2014) Efficacy and toxicity of chemo-radiotherapy in Hodgkin's lymphoma: a single intitution experience. Radiother Oncol 11: 423.
21. Cella L, Conson M, Caterino M, De Rosa N, Liuzzi R, et al. (2012) Thyroid V30 Predicts Radiation-Induced Hypothyroidism in Patients Treated With Sequential Chemo-Radiotherapy for Hodgkin's Lymphoma. Int J Radiat Oncol Biol Phys 82: 1802-1808.
22. Cella L, Liuzzi R, Conson M, Torre G, Caterino M, et al. (2011) Dosimetric predictors of asymptomatic heart valvular dysfunction following mediastinal irradiation for Hodgkin's lymphoma. Radiother Oncol 101: 316-321.
23. Cella L, Liuzzi R, Magliulo M, Conson M, Camera L, et al. (2010) Radiotherapy of large target volumes in Hodgkin's lymphoma: normal tissue sparing capability of forward IMRT versus conventional techniques. Radiat Oncol 5: 33.
24. Feng M, Moran JM, Koelling T, Chughtai A, Chan JL, et al. (2011) Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer. Int J Radiat Oncol Biol Phys 79: 10-18.
25. Kong FM, Ritter T, Quint DJ, Senan S, Gaspar LE, et al. (2011) Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus. Int J Radiat Oncol Biol Phys 81: 1442-1457.
26. Deasy JO, Blanco AI, Clark VH (2003) CERR: a computational environment for radiotherapy research. Med Phys 30: 979-985.
27. Marks LB, Yorke ED, Jackson A, Ten Haken RK, Constine LS, et al. (2010) Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys 76: S10-19.
28. Joiner MC, Bentzen SM, Bauman DE (2002) Time-dose relationships: the linear-quadratic approach and the model in clinical practice, Steel GG (ed) Basic clinical radiobiology. 120-146 p.
29. Bentzen SM, Skoczylas JZ, Bernier J (2000) Quantitative clinical radiobiology of early and late lung reactions. Int J Radiat Biol 76: 453-462.
30. Venzon DJ, Moolgavkar SH (1988) A Method for Computing Profile-Likelihood-Based Confidence Intervals. Journal of the Royal Statistical Society Series C (Applied Statistics) 37: 87-94.
31. Semenenko VA, Li XA (2008) Lyman-Kutcher-Burman NTCP model parameters for radiation pneumonitis and xerostomia based on combined analysis of published clinical data. Phys Med Biol 53: 737-755.
32. Deasy JO, Chao KS, Markman J (2001) Uncertainties in model-based outcome predictions for treatment planning. Int J Radiat Oncol Biol Phys 51: 1389-1399.
33. Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, et al. (2010) Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology 21: 128-138.
34. Andratschke N, Maurer J, Molls M, Trott KR (2010) Late radiation-induced heart disease after radiotherapy. Clinical importance, radiobiological mechanisms and strategies of prevention. Radiother Oncol.
35. Schellong G, Riepenhausen M, Bruch C, Kotthoff S, Vogt J, et al. (2010) Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for Hodgkin disease in children and adolescents: report from the longitudinal GPOH follow-up project of the German-Austrian DAL-HD studies. Pediatr Blood Cancer 55: 1145-1152.
36. Adams MJ, Hardenbergh PH, Constine LS, Lipshultz SE (2003) Radiation-associated cardiovascular disease. Crit Rev Oncol Hematol 45: 55-75.
37. Ghobadi G, van der Veen S, Bartelds B, de Boer RA, Dickinson MG, et al. (2012) Physiological interaction of heart and lung in thoracic irradiation. Int J Radiat Oncol Biol Phys 84: e639-646.
38. van Luijk P, Novakova-Jiresova A, Faber H, Schippers JM, Kampinga HH, et al. (2005) Radiation damage to the heart enhances early radiation-induced lung function loss. Cancer Res 65: 6509-6511.
39. Bentzen SM (1994) Prediction of radiotherapy response using SF2: why it may work after all. Radiother Oncol 31: 85-86.
40. Cella L, Liuzzi R, Conson M, V DA, Salvatore M, et al. (2012) Development of multivariate NTCP models for radiation-induced hypothyroidism: a comparative analysis. Radiat Oncol 7: 224.
41. Lee TF, Chao PJ, Ting HM, Chang L, Huang YJ, et al. (2014) Using Multivariate Regression Model with Least Absolute Shrinkage and Selection Operator (LASSO) to Predict the Incidence of Xerostomia after Intensity-Modulated Radiotherapy for Head and Neck Cancer. PLoS One 9: e89700.
42. Huang EX, Hope AJ, Lindsay PE, Trovo M, El Naqa I, et al. (2011) Heart irradiation as a risk factor for radiation pneumonitis. Acta Oncol 50: 51-60.